Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000278113, commonly abbreviated as TUC338, corresponds to a non-coding RNA transcript registered in the Ensembl and RFAM databases[7]. It is not a protein-coding gene, receptor, enzyme, or transporter and has no established role as a therapeutic target, biomarker, or drug interactor based on current curated resources. There is no evidence that it has a defined biological function, molecular family, or disease association, and its classification is limited to miscellaneous non-coding RNA. This means the entry is not suited for structured annotation as a canonical biomedical target such as a receptor or enzyme, and its inclusion as a "target" is likely incorrect or based on misunderstanding of its gene type, per available public gene databases[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcribed ultra-conserved RNA 338 (TUC338).